-Raddur Samaddar, Team bioXone While the world is waiting for a COVID-19 vaccine with absolute eagerness, the closest promising immunological treatment that can help stop the rate of the ever-increasing spread of the SARS-CoV-2 virus is the Convalescent Plasma Therapy. This treatment relies upon the transfusion of the anti-viral antibodies from donors to recipients with […]
Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]
Anwita Sarkar, Team BioXone Based on what we know so far about the complications of COVID-19, it frequently involves complications that bear similarities to autoimmune disorders. Up to now, there are little reports on possible IgA mediated autoimmune responses. A study was conducted to determine the association of COVID-19 with vigorous total IgA responses. It […]
–Anuska Sen, Team bioXone While the entire nation unanimously waits for India’s Covid-19 vaccine, there are various drawbacks and negativities regarding the vaccine that keeps on upsetting the world, particularly Indians. However, another disheartening news has been reported today. AstraZeneca’s Covid-19 vaccine has been paused by its partner, the Serum Institute of India. Earlier this […]
